GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Researchers at Cornell University's SC Johnson College of Business found that households with at least one GLP-1 user reduced grocery spending by 5.3% within six months of starting treatment. Higher-income households saw even steeper declines of 8.2%. Warning! GuruFocus has detected 5 Warning Signs with NVDA. Is LLY fairly valued? Test your thesis with our free DCF calculator. The study examined users of popular obesity drugs such as Novo Nordisk's ( NYSE:NVO ) Wegovy and Eli Lilly ( NYSE:LLY ) and Company's Zepbound and was published in the Journal of Marketing Research. The sharpest pullbacks were concentrated in calorie-dense, processed foods, with spending on savory snacks falling 10.1%. Outlays at fast-food restaurants, coffee shops, and other limited-service dining venues dropped about 8%. Some healthier categories, such as yogurt, saw modest increases. Notably, researchers found food purchases tend to revert once GLP-1 use ends, underscoring both the scale and limits
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways [Yahoo! Finance]Yahoo! Finance
- Should You Invest in Ozempic Maker Novo Nordisk in 2026? [Yahoo! Finance]Yahoo! Finance
- Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access [Yahoo! Finance]Yahoo! Finance
- Health care will get more expensive for some in 2026 — and cheaper for others [MSNBC.com]MSNBC.com
- Novo Nordisk (CPSE:NOVO B) Is Up 9.0% After FDA Clears First Oral Wegovy Pill [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website